 |
|
|
| |
Retreatment with SOF/VEL/VOX in Treatment-Experienced
Patients with and without HIV: The RESOLVE Study
|
| |
| |
RReported by Jules Levin
AASLD 2018 Nov 9-12 Boston
Emily Covert 1, 2, Jennifer Hoffmann1, Ben Emmanuel1, Emily Comstock1, Lydia Tang1, Sarah Kattakuzhy1,
Elana Rosenthal1, Poonam Mathur1, Henry Masur2, Shyam Kottilil1, Eleanor Wilson1
1. Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201
2. Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892
|
| |
|
|
|
|
|
